Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
01/02/2008 | EP1871743A1 Antiparasitic compounds |
01/02/2008 | EP1656361B1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
01/02/2008 | EP1390664A4 Materials, methods, and uses for photochemical generation of acids and/or radical species |
01/02/2008 | CN101095675A Dipeptidyl peptidase IV effectors |
01/01/2008 | US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed |
01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
01/01/2008 | US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide |
12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
12/27/2007 | WO2007148558A1 Active ray curable composition, method for curing the same, active ray curable ink composition, image forming method, and compound |
12/27/2007 | WO2007148208A2 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
12/27/2007 | WO2007147839A1 Glycine transporter inhibiting compounds and uses in medicine |
12/27/2007 | WO2007147834A1 Glycine transporter inhibiting compounds and uses in medicine |
12/27/2007 | WO2007147824A1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists |
12/27/2007 | WO2007147822A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
12/27/2007 | WO2007147346A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
12/27/2007 | WO2007092558A3 Sulfonamide derivatives to treat infection with hepatitis c virus |
12/27/2007 | WO2007092435A3 11-beta hsd1 inhibitors |
12/27/2007 | WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
12/27/2007 | WO2007047305A8 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
12/27/2007 | WO2004058735A3 Ligands of melanocortin receptors and compositions and methods related thereto |
12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
12/27/2007 | US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
12/27/2007 | US20070295592 Method for Improving a Piperazine Colour Stability |
12/27/2007 | CA2655728A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
12/27/2007 | CA2655654A1 New carbonylated (aza)cyclohexanes as dopamine d3 receptor ligands |
12/27/2007 | CA2655527A1 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists |
12/26/2007 | EP1870405A1 Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
12/26/2007 | EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors |
12/26/2007 | EP1868982A2 Compounds that stimulate glucose utilization and methods of use |
12/26/2007 | EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
12/26/2007 | CN101094835A Novel dicarboxamide derivatives |
12/26/2007 | CN101092401A Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
12/26/2007 | CN100357258C Production of keto acids |
12/25/2007 | US7312246 Inhibiting interaction of alpha-helical protein with another protein or binding site; inhibiting cellular invasion of HIV |
12/25/2007 | US7312235 Anticoagulants |
12/25/2007 | US7311860 Refluxing 1,3,5-tricyanomethylstylene with N-formylamine dimethylacetal or substituted benzaldehyde, or by the Wittig reaction of 1,3,5-tricyano-2,4,6-tris[(diethylphosphoryl)methyl]benzene with substituted benzaldehyde; hyperpolarizability in solution; useful as optical devices |
12/21/2007 | WO2007144639A1 2 -oxybenzamide derivatives as parp inhibitors |
12/21/2007 | WO2007144005A1 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
12/21/2007 | WO2007118963A3 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof |
12/21/2007 | WO2006103342A8 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same |
12/21/2007 | CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
12/20/2007 | US20070293683 N-phenyl-2-pyrimidine-amine derivatives |
12/20/2007 | US20070293673 N-phenyl-2-pyrimidine-amine derivatives |
12/20/2007 | US20070293672 N-phenyl-2-pyrimidine-amine derivatives |
12/20/2007 | US20070293504 N-phenyl-2-pyrimidine-amine derivatives |
12/20/2007 | US20070293502 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof |
12/20/2007 | US20070293499 Intracellular Kinase Inhibitors |
12/20/2007 | US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
12/20/2007 | US20070293491 Indazole compounds and methods for inhibition of cdc7 |
12/19/2007 | EP1866298A2 Hydroxysteroid dehydrogenase inhibitors |
12/19/2007 | EP1701946B1 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
12/19/2007 | EP1313560B1 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION |
12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
12/19/2007 | CN101090904A Enantioselective phosphoramidite compounds and catalysts |
12/19/2007 | CN101090883A Substituted hydroxyethylamines |
12/19/2007 | CN101090724A Heterocyclic derivatives and their use as therapeutic agents |
12/19/2007 | CN101088993A NMMO evaporating process |
12/19/2007 | CN100355728C Inhibitors of dipeptidyl peptidase IV |
12/19/2007 | CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity |
12/18/2007 | US7309787 2-Substituted spiro[cyclopropane-1,3'-indolin-2'-ones]: morpholinylphenyl-, piperidinylethylphenyl-, 3-(carboxyethyl)-4-methylpyrrol-2-yl-, pyrazolon-2-yl-, 4-methylimidazol-5-yl-; vascular endothelial growth factor inhibitors; regulate, modulate and/or inhibit abnormal cell proliferation |
12/18/2007 | US7309714 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
12/18/2007 | US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
12/13/2007 | WO2007142431A1 New non-peptide compounds, process for the preparation thereof and pharmaceutical composition comprising the same |
12/13/2007 | WO2007117981A3 Selective hydroxamate based mmp inhibitors |
12/13/2007 | WO2007070506A3 Diaza heterocyclic sulfonamide derivatives and their uses |
12/13/2007 | US20070287730 useful for the treatment of HIV and AIDS |
12/13/2007 | US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections |
12/13/2007 | CA2654784A1 Substituted phenylacetic acids as dp-2 antagonists |
12/12/2007 | EP1863780A1 Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein |
12/12/2007 | EP1863779A1 Addition salts of tolperisone, processes for their preparation and use thereof |
12/12/2007 | EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
12/12/2007 | EP1237859B1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
12/12/2007 | EP0927174B1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds |
12/12/2007 | CN101087771A Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds |
12/12/2007 | CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
12/12/2007 | CN101087752A Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics |
12/12/2007 | CN101085762A Ionic liquid containing N-cyanoalkyl-N-alkylmorphinone cation and preparation method thereof |
12/12/2007 | CN100354271C Piperazine derivatives and process for the preparation thereof |
12/11/2007 | US7307169 Isotopically enriched N-substituted piperazines and methods for the preparation thereof |
12/11/2007 | US7307163 Process for the preparation of linezolid and related compounds |
12/11/2007 | US7307091 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
12/11/2007 | US7307078 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof |
12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
12/06/2007 | WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c |
12/06/2007 | WO2007137990A1 Process for the preparation of an amine |
12/06/2007 | WO2007137738A1 Spirocyclic nitriles as protease inhibitors |
12/06/2007 | WO2007064842A3 Synthesis of chlorins and phorbines with enhanced red spectral features |
12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
12/06/2007 | US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis |
12/06/2007 | US20070281933 Novel Indazole Carboxamides And Their Use |
12/06/2007 | CA2667854A1 Tagging reagents and methods for hydroxylated compounds |
12/06/2007 | CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c |
12/06/2007 | CA2653662A1 Spirocyclic nitriles as protease inhibitors |
12/05/2007 | EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
12/05/2007 | EP1861358A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist, and pharmaceutical compositions containing the same |
12/05/2007 | EP1861357A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |